je.st
news
Biotech firm Aperion Biologics ready to launch first device in Europe
2014-12-05 01:59:33| Biotech - Topix.net
Daniel Lee, CEO of Aperion Biologics Inc., is set to break into the European biotechnology market with its new Z-Lig ligament reconstruction device. Aperion Biologics , one of several San Antonio-based bioscience firms that had an opportunity to pitch to potential investors on Thursday during the World Stem Cell Summit's inaugural RegMed Capital Conference, is only weeks away from rolling out its initial product.
Tags: europe
ready
firm
device
Category:Biotechnology and Pharmaceuticals